The CRISPR-Cas technology is aÌýversatile genome editing toolÌýthat has been used to improve agriculturally important crop traits, such as quality, disease resistance, and herbicide tolerance.
Highlights
The global CRISPR in Agriculture market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for CRISPR in Agriculture is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for CRISPR in Agriculture is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for CRISPR in Agriculture in Academic & Research Institutes is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of CRISPR in Agriculture include Arcadia Biosciences, Bayer AG, BASF SE, Beam Therapeutics Inc., Benson Hill Biosystems, Inc., Caribou Bioscience Inc., Calyxt, Inc., Cellectis SA and Cibus, Ltd., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CRISPR in Agriculture, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR in Agriculture.
The CRISPR in Agriculture market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global CRISPR in Agriculture market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR in Agriculture companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Arcadia Biosciences
Bayer AG
BASF SE
Beam Therapeutics Inc.
Benson Hill Biosystems, Inc.
Caribou Bioscience Inc.
Calyxt, Inc.
Cellectis SA
Cibus, Ltd.
CRISPR Therapeutics AG
DeciBio, LLC
E. I. du Pont de Nemours and Co.
Evogene Ltd.
GeneCopoeia inc.
Horizon Discovery Group PLC
Intellia Therapeutics, Inc.
J.R. Simplot Co.
Pairwise Plants
Synthetic Genomics Inc.
Tropic Biosciences UK LTD.
Yield10 Bioscience, Inc.
Segment by Type
Crops
Livestock
Aquaculture
Segment by Application
Academic & Research Institutes
Biotech Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR in Agriculture companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global CRISPR in Agriculture Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Crops
1.2.3 Livestock
1.2.4 Aquaculture
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global CRISPR in Agriculture Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Academic & Research Institutes
1.3.3 Biotech Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR in Agriculture Âé¶¹Ô´´ Perspective (2018-2029)
2.2 CRISPR in Agriculture Growth Trends by Region
2.2.1 Global CRISPR in Agriculture Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 CRISPR in Agriculture Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 CRISPR in Agriculture Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 CRISPR in Agriculture Âé¶¹Ô´´ Dynamics
2.3.1 CRISPR in Agriculture Industry Trends
2.3.2 CRISPR in Agriculture Âé¶¹Ô´´ Drivers
2.3.3 CRISPR in Agriculture Âé¶¹Ô´´ Challenges
2.3.4 CRISPR in Agriculture Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR in Agriculture Players by Revenue
3.1.1 Global Top CRISPR in Agriculture Players by Revenue (2018-2023)
3.1.2 Global CRISPR in Agriculture Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global CRISPR in Agriculture Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR in Agriculture Revenue
3.4 Global CRISPR in Agriculture Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global CRISPR in Agriculture Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR in Agriculture Revenue in 2022
3.5 CRISPR in Agriculture Key Players Head office and Area Served
3.6 Key Players CRISPR in Agriculture Product Solution and Service
3.7 Date of Enter into CRISPR in Agriculture Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR in Agriculture Breakdown Data by Type
4.1 Global CRISPR in Agriculture Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global CRISPR in Agriculture Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 CRISPR in Agriculture Breakdown Data by Application
5.1 Global CRISPR in Agriculture Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global CRISPR in Agriculture Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America CRISPR in Agriculture Âé¶¹Ô´´ Size (2018-2029)
6.2 North America CRISPR in Agriculture Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America CRISPR in Agriculture Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America CRISPR in Agriculture Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR in Agriculture Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe CRISPR in Agriculture Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe CRISPR in Agriculture Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe CRISPR in Agriculture Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR in Agriculture Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific CRISPR in Agriculture Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific CRISPR in Agriculture Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific CRISPR in Agriculture Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR in Agriculture Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America CRISPR in Agriculture Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America CRISPR in Agriculture Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America CRISPR in Agriculture Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR in Agriculture Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa CRISPR in Agriculture Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa CRISPR in Agriculture Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa CRISPR in Agriculture Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arcadia Biosciences
11.1.1 Arcadia Biosciences Company Detail
11.1.2 Arcadia Biosciences Business Overview
11.1.3 Arcadia Biosciences CRISPR in Agriculture Introduction
11.1.4 Arcadia Biosciences Revenue in CRISPR in Agriculture Business (2018-2023)
11.1.5 Arcadia Biosciences Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Detail
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG CRISPR in Agriculture Introduction
11.2.4 Bayer AG Revenue in CRISPR in Agriculture Business (2018-2023)
11.2.5 Bayer AG Recent Development
11.3 BASF SE
11.3.1 BASF SE Company Detail
11.3.2 BASF SE Business Overview
11.3.3 BASF SE CRISPR in Agriculture Introduction
11.3.4 BASF SE Revenue in CRISPR in Agriculture Business (2018-2023)
11.3.5 BASF SE Recent Development
11.4 Beam Therapeutics Inc.
11.4.1 Beam Therapeutics Inc. Company Detail
11.4.2 Beam Therapeutics Inc. Business Overview
11.4.3 Beam Therapeutics Inc. CRISPR in Agriculture Introduction
11.4.4 Beam Therapeutics Inc. Revenue in CRISPR in Agriculture Business (2018-2023)
11.4.5 Beam Therapeutics Inc. Recent Development
11.5 Benson Hill Biosystems, Inc.
11.5.1 Benson Hill Biosystems, Inc. Company Detail
11.5.2 Benson Hill Biosystems, Inc. Business Overview
11.5.3 Benson Hill Biosystems, Inc. CRISPR in Agriculture Introduction
11.5.4 Benson Hill Biosystems, Inc. Revenue in CRISPR in Agriculture Business (2018-2023)
11.5.5 Benson Hill Biosystems, Inc. Recent Development
11.6 Caribou Bioscience Inc.
11.6.1 Caribou Bioscience Inc. Company Detail
11.6.2 Caribou Bioscience Inc. Business Overview
11.6.3 Caribou Bioscience Inc. CRISPR in Agriculture Introduction
11.6.4 Caribou Bioscience Inc. Revenue in CRISPR in Agriculture Business (2018-2023)
11.6.5 Caribou Bioscience Inc. Recent Development
11.7 Calyxt, Inc.
11.7.1 Calyxt, Inc. Company Detail
11.7.2 Calyxt, Inc. Business Overview
11.7.3 Calyxt, Inc. CRISPR in Agriculture Introduction
11.7.4 Calyxt, Inc. Revenue in CRISPR in Agriculture Business (2018-2023)
11.7.5 Calyxt, Inc. Recent Development
11.8 Cellectis SA
11.8.1 Cellectis SA Company Detail
11.8.2 Cellectis SA Business Overview
11.8.3 Cellectis SA CRISPR in Agriculture Introduction
11.8.4 Cellectis SA Revenue in CRISPR in Agriculture Business (2018-2023)
11.8.5 Cellectis SA Recent Development
11.9 Cibus, Ltd.
11.9.1 Cibus, Ltd. Company Detail
11.9.2 Cibus, Ltd. Business Overview
11.9.3 Cibus, Ltd. CRISPR in Agriculture Introduction
11.9.4 Cibus, Ltd. Revenue in CRISPR in Agriculture Business (2018-2023)
11.9.5 Cibus, Ltd. Recent Development
11.10 CRISPR Therapeutics AG
11.10.1 CRISPR Therapeutics AG Company Detail
11.10.2 CRISPR Therapeutics AG Business Overview
11.10.3 CRISPR Therapeutics AG CRISPR in Agriculture Introduction
11.10.4 CRISPR Therapeutics AG Revenue in CRISPR in Agriculture Business (2018-2023)
11.10.5 CRISPR Therapeutics AG Recent Development
11.11 DeciBio, LLC
11.11.1 DeciBio, LLC Company Detail
11.11.2 DeciBio, LLC Business Overview
11.11.3 DeciBio, LLC CRISPR in Agriculture Introduction
11.11.4 DeciBio, LLC Revenue in CRISPR in Agriculture Business (2018-2023)
11.11.5 DeciBio, LLC Recent Development
11.12 E. I. du Pont de Nemours and Co.
11.12.1 E. I. du Pont de Nemours and Co. Company Detail
11.12.2 E. I. du Pont de Nemours and Co. Business Overview
11.12.3 E. I. du Pont de Nemours and Co. CRISPR in Agriculture Introduction
11.12.4 E. I. du Pont de Nemours and Co. Revenue in CRISPR in Agriculture Business (2018-2023)
11.12.5 E. I. du Pont de Nemours and Co. Recent Development
11.13 Evogene Ltd.
11.13.1 Evogene Ltd. Company Detail
11.13.2 Evogene Ltd. Business Overview
11.13.3 Evogene Ltd. CRISPR in Agriculture Introduction
11.13.4 Evogene Ltd. Revenue in CRISPR in Agriculture Business (2018-2023)
11.13.5 Evogene Ltd. Recent Development
11.14 GeneCopoeia inc.
11.14.1 GeneCopoeia inc. Company Detail
11.14.2 GeneCopoeia inc. Business Overview
11.14.3 GeneCopoeia inc. CRISPR in Agriculture Introduction
11.14.4 GeneCopoeia inc. Revenue in CRISPR in Agriculture Business (2018-2023)
11.14.5 GeneCopoeia inc. Recent Development
11.15 Horizon Discovery Group PLC
11.15.1 Horizon Discovery Group PLC Company Detail
11.15.2 Horizon Discovery Group PLC Business Overview
11.15.3 Horizon Discovery Group PLC CRISPR in Agriculture Introduction
11.15.4 Horizon Discovery Group PLC Revenue in CRISPR in Agriculture Business (2018-2023)
11.15.5 Horizon Discovery Group PLC Recent Development
11.16 Intellia Therapeutics, Inc.
11.16.1 Intellia Therapeutics, Inc. Company Detail
11.16.2 Intellia Therapeutics, Inc. Business Overview
11.16.3 Intellia Therapeutics, Inc. CRISPR in Agriculture Introduction
11.16.4 Intellia Therapeutics, Inc. Revenue in CRISPR in Agriculture Business (2018-2023)
11.16.5 Intellia Therapeutics, Inc. Recent Development
11.17 J.R. Simplot Co.
11.17.1 J.R. Simplot Co. Company Detail
11.17.2 J.R. Simplot Co. Business Overview
11.17.3 J.R. Simplot Co. CRISPR in Agriculture Introduction
11.17.4 J.R. Simplot Co. Revenue in CRISPR in Agriculture Business (2018-2023)
11.17.5 J.R. Simplot Co. Recent Development
11.18 Pairwise Plants
11.18.1 Pairwise Plants Company Detail
11.18.2 Pairwise Plants Business Overview
11.18.3 Pairwise Plants CRISPR in Agriculture Introduction
11.18.4 Pairwise Plants Revenue in CRISPR in Agriculture Business (2018-2023)
11.18.5 Pairwise Plants Recent Development
11.19 Synthetic Genomics Inc.
11.19.1 Synthetic Genomics Inc. Company Detail
11.19.2 Synthetic Genomics Inc. Business Overview
11.19.3 Synthetic Genomics Inc. CRISPR in Agriculture Introduction
11.19.4 Synthetic Genomics Inc. Revenue in CRISPR in Agriculture Business (2018-2023)
11.19.5 Synthetic Genomics Inc. Recent Development
11.20 Tropic Biosciences UK LTD.
11.20.1 Tropic Biosciences UK LTD. Company Detail
11.20.2 Tropic Biosciences UK LTD. Business Overview
11.20.3 Tropic Biosciences UK LTD. CRISPR in Agriculture Introduction
11.20.4 Tropic Biosciences UK LTD. Revenue in CRISPR in Agriculture Business (2018-2023)
11.20.5 Tropic Biosciences UK LTD. Recent Development
11.21 Yield10 Bioscience, Inc.
11.21.1 Yield10 Bioscience, Inc. Company Detail
11.21.2 Yield10 Bioscience, Inc. Business Overview
11.21.3 Yield10 Bioscience, Inc. CRISPR in Agriculture Introduction
11.21.4 Yield10 Bioscience, Inc. Revenue in CRISPR in Agriculture Business (2018-2023)
11.21.5 Yield10 Bioscience, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Arcadia Biosciences
Bayer AG
BASF SE
Beam Therapeutics Inc.
Benson Hill Biosystems, Inc.
Caribou Bioscience Inc.
Calyxt, Inc.
Cellectis SA
Cibus, Ltd.
CRISPR Therapeutics AG
DeciBio, LLC
E. I. du Pont de Nemours and Co.
Evogene Ltd.
GeneCopoeia inc.
Horizon Discovery Group PLC
Intellia Therapeutics, Inc.
J.R. Simplot Co.
Pairwise Plants
Synthetic Genomics Inc.
Tropic Biosciences UK LTD.
Yield10 Bioscience, Inc.
Ìý
Ìý
*If Applicable.